News

Poxel’s Imeglimin Targets Mitochondrial Dysfunction in Type 2 Diabetes

Poxel SA, a biopharmaceutical company dedicated to novel treatments for type 2 diabetes, recently announced the presentation of preclinical data on Imeglimin, the company’s first-in-class lead anti-diabetic product, at the 6th World Congress on Targeting Mitochondria held in Berlin, Germany, Oct. 28–30, 2015. Imeglimin, an oral therapeutic agent…

Mitochondria Involvement in Aging Reinforced in Study

In a new study recently published in the journal Nature Communications, an international research team reported new insights into the molecular changes associated with aging, which reinforced the involvement of mitochondria in the aging process. The study is entitled “The transcriptional landscape of age…

Dysfunctional Mitochondria Found to Be Associated with Low Motile Sperm

In a new study entitled “Defective Human Sperm Cells Are Associated with Mitochondrial Dysfunction and Oxidant Production” researchers investigated if dysfunctional mitochondria were associated with defective sperm, thereby contributing to male infertility. The team’s findings suggest that indeed, low motile sperm is associated with defective mitochondria and…

Study Suggests Male and Female Fertility and Longevity are Affected by Mitochondrial Genome Mutations

New evidence suggests that mutations in mitochondrial DNA (mtDNA) may significantly affect fertility and life expectancy, with important differences in male and female organisms. The study, led by PhD student Florencia Camus (School of Biological Sciences at Monash University) and entitled “Single Nucleotides in the mtDNA Sequence Modify Mitochondrial Molecular…